ScholarIQanswers from OpenAlex & ORCID
Anna Maria Langkilde
ResearcherPublications, citations & collaboration network
Anna Maria Langkilde is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Anna Maria Langkilde have?
ScholarIQindexed works
Anna Maria Langkilde has 310 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Anna Maria Langkilde have?
ScholarIQcitation count
Anna Maria Langkilde has 22,467 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Anna Maria Langkilde?
ScholarIQh-index
Anna Maria Langkilde has an h-index of 75 in OpenAlex.
What is the i10-index of Anna Maria Langkilde?
ScholarIQi10-index
Anna Maria Langkilde has an i10-index of 174 in OpenAlex.
What is the ORCID of Anna Maria Langkilde?
ScholarIQorcid
The ORCID for Anna Maria Langkilde is on the source record.
What is the OpenAlex record for Anna Maria Langkilde?
ScholarIQopenalex
The OpenAlex for Anna Maria Langkilde is on the source record.
What are the most-cited papers on Anna Maria Langkilde?
ScholarIQmost cited works
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
Scott D. Solomon, John J.V. McMurray, Brian Claggett, Rudolf A. de Boer, David L. DeMets, Adrian F. Hernandez, Silvio E. Inzucchi, Mikhail Kosiborod, Carolyn S.P. Lam, Felipe A. Martínez, Sanjiv J. Shah, Akshay S. Desai, Pardeep S. Jhund, Jan Bělohlávek, Chern‐En Chiang, C. Jan Willem Borleffs, Josep Comín‐Colet, Dan Dobreanu, Jarosław Dróżdż, James C. Fang, Marco A. Alcocer‐Gamba, Waleed Al Habeeb, Yaling Han, Jose Walter Cabrera Honorio, Stefan Janssens, Tzvetana Katova, Masafumi Kitakaze, Béla Merkely, Eileen O’Meara, José Francisco Kerr Saraiva, С. Н. Терещенко, Jorge Thierer, Muthiah Vaduganathan, Orly Vardeny, Subodh Verma, Vinh Pham, Ulrica Wilderäng, Natalia Zaozerska, Erasmus Bachus, Daniel Lindholm, Magnus Petersson, Anna Maria Langkilde
Effects of Dapagliflozin on Body Weight, Total Fat Mass, and Regional Adipose Tissue Distribution in Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on Metformin
Jan Bolinder, Östen Ljunggren, Joel Kullberg, Lars Johansson, John Wilding, Anna Maria Langkilde, Jennifer Sugg, Shamik Parikh
Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE–TIMI 58 randomised trial
Ofri Mosenzon, Stephen D. Wiviott, Avivit Cahn, Aliza Rozenberg, Ilan Yanuv, Erica L. Goodrich, Sabina A. Murphy, Hiddo J.L. Heerspink, Thomas A. Zelniker, Jamie P. Dwyer, Deepak L. Bhatt, Lawrence A. Leiter, Darren K. McGuire, John Wilding, Eri Kato, Ingrid Gause‐Nilsson, Martin Fredriksson, Peter A. Johansson, Anna Maria Langkilde, Marc S. Sabatine, Itamar Raz
Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus
Eri Kato, Michael G. Silverman, Ofri Mosenzon, Thomas A. Zelniker, Avivit Cahn, Remo H.M. Furtado, Julia Kuder, Sabina A. Murphy, Deepak L. Bhatt, Lawrence A. Leiter, Darren K. McGuire, John Wilding, Marc P. Bonaca, Christian T. Ruff, Akshay S. Desai, Shinya Goto, Peter A. Johansson, Ingrid Gause‐Nilsson, Per Johanson, Anna Maria Langkilde, Itamar Raz, Marc S. Sabatine, Stephen D. Wiviott
Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes
Mark C. Petrie, Subodh Verma, Kieran F. Docherty, Silvio E. Inzucchi, Inder S. Anand, Jan Bělohlávek, Michael Böhm, Chern‐En Chiang, Vijay Chopra, Rudolf A. de Boer, Akshay S. Desai, Mirta Díez, Jarosław Dróżdż, Andre Dukát, Junbo Ge, Jonathan G. Howlett, Tzvetana Katova, Masafumi Kitakaze, Charlotta Ljungman, Béla Merkely, José Carlos Nicolau, Eileen O’Meara, Pham Nguyễn Vinh, Morten Schou, С. Н. Терещенко, Lars Køber, Mikhail Kosiborod, Anna Maria Langkilde, Felipe A. Martínez, Piotr Ponikowski, Marc S. Sabatine, Mikaela Sjöstrand, Scott D. Solomon, Per Johanson, Peter J. Greasley, David W. Boulton, Olof Bengtsson, Pardeep S. Jhund, John J.V. McMurray